RadNet's 2025 Q2 Earnings Call: Key Contradictions in Advanced Imaging Growth and AI Revenue Trends

Advanced Imaging growth drivers, EBCD adoption and reimbursement, iCAD integration and cross-selling opportunities, AI revenue trends, DeepHealth integration and cost structure are the key contradictions discussed in RadNet's latest 2025Q2 earnings call.



Revenue and Profit Growth:
- RadNet reported record revenue of $498.2 million for Q2 2025, up 8.4% year-on-year.
- The growth was driven by increased utilization of diagnostic imaging, improved reimbursement rates, and advanced imaging initiatives.

Advanced Imaging Expansion:
- Advanced imaging grew 9% in aggregate and 6.6% on a same-center basis, with PET/CT showing a 22.4% increase in aggregate and 16.2% on a same-center basis.
- The expansion was due to enhanced reimbursement rates, increased demand for complex procedures, and initiatives like TechLive and FDA-cleared tools.

Digital Health Segment Performance:
- RadNet's Digital Health segment achieved $20.7 million in revenue, a 30.9% increase year-on-year.
- This growth was supported by increased adoption of EBCD programs and expanded licensing of DeepHealth solutions.

Effect of TechLive on Capacity:
- TechLive reduced MRI room closures by 42% in the New York area, significantly expanding hours of operation.
- This technology enabled remote scanning and improved operational efficiency, enhancing RadNet's ability to handle increased procedure volumes.